Cryoport, Inc. (CYRX)
18.64
+0.22
(+1.22%)
USD |
NASDAQ |
Oct 28, 16:00
18.64
0.00 (0.00%)
After-Hours: 20:00
Cryoport Enterprise Value : 814.04M for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 814.04M |
| October 26, 2026 | 782.64M |
| October 23, 2026 | 792.26M |
| October 22, 2026 | 784.66M |
| October 21, 2026 | 820.12M |
| October 20, 2026 | 764.91M |
| October 19, 2026 | 741.61M |
| October 16, 2026 | 734.52M |
| October 15, 2026 | 746.17M |
| October 14, 2026 | 724.39M |
| October 13, 2026 | 740.09M |
| October 12, 2026 | 734.52M |
| October 09, 2026 | 760.35M |
| October 08, 2026 | 737.56M |
| October 07, 2026 | 760.35M |
| October 06, 2026 | 783.14M |
| October 05, 2026 | 800.36M |
| October 02, 2026 | 764.40M |
| October 01, 2026 | 760.86M |
| September 30, 2026 | 762.88M |
| September 29, 2026 | 758.83M |
| September 28, 2026 | 761.87M |
| September 25, 2026 | 763.39M |
| September 24, 2026 | 762.88M |
| September 23, 2026 | 767.44M |
| Date | Value |
|---|---|
| September 22, 2026 | 771.49M |
| September 21, 2026 | 774.03M |
| September 18, 2026 | 743.64M |
| September 17, 2026 | 731.48M |
| September 16, 2026 | 717.81M |
| September 15, 2026 | 707.68M |
| September 14, 2026 | 689.95M |
| September 11, 2026 | 669.18M |
| September 10, 2026 | 655.00M |
| September 09, 2026 | 648.42M |
| September 08, 2026 | 665.13M |
| September 04, 2026 | 682.35M |
| September 03, 2026 | 684.89M |
| September 02, 2026 | 680.83M |
| September 01, 2026 | 669.18M |
| August 31, 2026 | 691.98M |
| August 28, 2026 | 696.53M |
| August 27, 2026 | 720.85M |
| August 26, 2026 | 720.85M |
| August 25, 2026 | 728.44M |
| August 24, 2026 | 709.20M |
| August 21, 2026 | 749.21M |
| August 20, 2026 | 727.94M |
| August 19, 2026 | 707.68M |
| August 18, 2026 | 645.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 58.99B |
| Protect Pharmaceutical Corp. | 4.314M |
| Champions Oncology, Inc. | 74.41M |
| Medpace Holdings, Inc. | 18.26B |
| Charles River Laboratories International, Inc. | 19.99B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.255M |
| Revenue (Quarterly) | 48.97M |
| Total Expenses (Quarterly) | 57.23M |
| EPS Diluted (Quarterly) | -0.2033 |
| Gross Profit Margin (Quarterly) | 39.66% |
| Profit Margin (Quarterly) | -16.86% |
| Earnings Yield | -4.38% |
| Normalized Earnings Yield | -4.414 |